---
{"dg-publish":true,"permalink":"/0-inbox/musculoskeletal-disorder-summary/","created":"2024-02-18T12:52:32.685+07:00","updated":"2025-10-06T19:48:34.878+07:00"}
---

**Author:** ‡∏û‡∏≠‡∏à‡∏≠ c91 rx80 üíò
**Publish Date:** [[2024-03-17\|2024-03-17]]
**Note:** ‡πÇ‡∏õ‡∏£‡∏î‡∏≠‡πà‡∏≤‡∏ô‡∏ï‡∏≤‡∏°‡∏®‡∏£‡∏±‡∏ó‡∏ò‡∏≤ ‡πÅ‡∏•‡∏∞‡∏≠‡∏¢‡πà‡∏≤‡πÇ‡∏õ‡∏£‡∏î‡∏ß‡πà‡∏≤‡∏Å‡∏±‡∏ô‡∏ñ‡πâ‡∏≤‡∏°‡∏µ‡∏™‡∏£‡∏∏‡∏õ‡∏ú‡∏¥‡∏î; summary for PC1 only
Polymyositis, Degenerative joint disease, drug induced bone and joint / rheumatic ‡πÑ‡∏°‡πà‡πÑ‡∏î‡πâ‡∏ó‡∏≥‡∏™‡∏£‡∏∏‡∏õ‡πÉ‡∏ô‡∏ô‡∏µ‡πâ SLE ‡πÑ‡∏õ‡∏ó‡∏≥‡∏™‡∏£‡∏∏‡∏õ‡πÉ‡∏ô immunologic disorder
# Gout
- Associated Note: [[2 Areas/University/Gout\|Gout]], [[2 Areas/University/NSAIDs\|NSAIDs]], [[2 Areas/University/Uric Lowering Agent\|Uric Lowering Agent]]
- Etiology: increased uptake, decreased excretion, cell lysis, drug induced
- Pathophysiology: oversaturation of uric acid (more than 6 female or 7 men) causing formation of monosodium urate crystal -> can deposit in many organ but mostly involve joint (can also cause [[0 Inbox/Nephrolithiasis\|Nephrolithiasis]])
- Diagnosis: ‡πÄ‡∏à‡∏≤‡∏∞‡∏Ç‡πâ‡∏≠
- ROME Criteria 2 in 4: ‡πÉ‡∏ä‡πâ‡∏ß‡∏¥‡∏ô‡∏¥‡∏à‡∏â‡∏±‡∏¢‡∏Å‡∏£‡∏ì‡∏µ‡πÄ‡∏à‡∏≤‡∏∞‡∏Ç‡πâ‡∏≠‡∏î‡∏π‡πÑ‡∏°‡πà‡πÑ‡∏î‡πâ
	- **acute pain** ‡∏ó‡∏µ‡πà‡∏´‡∏≤‡∏¢‡πÄ‡∏≠‡∏á‡πÉ‡∏ô 2 weeks
	- tophus
	- elevated uric acid >6 female >7 male
	- found urate crystal in synovial fluid
- Criteria for ULT (ACR2020): ICFR
	- I - Inflammation (flare) more than 2 times
	- C - chronic / more than 1 tophus
	- F - Film
	- R (weak recommendation) - Renal impairment (‡πÅ‡∏ö‡∏ö‡∏î‡∏π‡∏ó‡∏£‡∏á‡πÅ‡∏•‡πâ‡∏ß‡∏ï‡πâ‡∏≠‡∏á‡πÉ‡∏ä‡πâ diuretics ‡∏ô‡∏π‡πà‡∏ô‡∏ô‡∏µ‡πà‡∏ô‡∏≤‡∏ô) ps. ‡πÑ‡∏°‡πà‡∏°‡∏µ‡∏≠‡∏≤‡∏Å‡∏≤‡∏£‡πÑ‡∏°‡πà‡∏ï‡πâ‡∏≠‡∏á‡πÉ‡∏ä‡πâ ‡πÅ‡∏•‡∏∞‡∏ï‡∏£‡∏á‡∏ô‡∏µ‡πâ‡πÄ‡∏õ‡πá‡∏ô‡πÅ‡∏Ñ‡πà conditionally recommended (renal impairment ‡∏Ñ‡∏∑‡∏≠ < 30)
- Management:
	- When to start ULT ([[2 Areas/University/Uric Lowering Agent\|Uric Lowering Agent]])?
		- ‡∏ñ‡πâ‡∏≤‡πÄ‡∏Ç‡πâ‡∏≤‡πÄ‡∏Å‡∏ì‡∏ë‡πå Criteria ICFR ‡∏Ç‡πâ‡∏≤‡∏á‡∏ö‡∏ô
		- Thai: ‡πÄ‡∏£‡∏¥‡πà‡∏°‡∏´‡∏•‡∏±‡∏á inflammation
		- ACR: ‡πÄ‡∏£‡∏¥‡πà‡∏°‡πÑ‡∏î‡πâ‡πÄ‡∏•‡∏¢‡πÑ‡∏°‡πà‡∏ï‡πâ‡∏≠‡∏á‡∏£‡∏≠
	- Acute Flare:
		- ‡∏≠‡∏¢‡πà‡∏≤‡∏•‡∏∑‡∏° **RICE**
		- No differ in efficacy b/w colchicine, [[2 Areas/University/NSAIDs\|NSAIDs]], [[0 Inbox/Steroid\|Steroid]] -> individualization
			- THAI -> ‡∏ö‡∏≠‡∏Å‡πÉ‡∏´‡πâ‡πÉ‡∏ä‡πâ colchicine first line
			- Prednisolone ‡∏Ñ‡∏ß‡∏£‡πÄ‡∏≠‡∏≤‡πÑ‡∏õ‡πÉ‡∏ä‡πâ‡∏™‡∏≥‡∏´‡∏£‡∏±‡∏ö‡∏Ñ‡∏ô‡∏ó‡∏µ‡πà‡πÉ‡∏ä‡πâ NSAIDs / Colchicine ‡πÑ‡∏°‡πà‡πÑ‡∏î‡πâ
		- Colchicine 1.2 mg po stat then 0.6 mg next 1 hr ‡∏ñ‡πâ‡∏≤‡πÑ‡∏°‡πà‡∏´‡∏≤‡∏¢ (max 1.8 mg/day)
			- adjust dose when eGFR < 30
			- CYP3A4 Substrate
			- ADR: Diarrhea, GI Bleeding
			- prophylaxis: 0.6 mg od
		- NSAIDs
		- NPO -> Use IM IA or IV glucocorticoids
	- Allopurinol
		- Thai: start ‡∏´‡∏•‡∏±‡∏á‡∏´‡∏≤‡∏¢ flare ‡πÄ‡∏û‡∏£‡∏≤‡∏∞‡∏Å‡∏•‡∏±‡∏ß‡∏£‡∏µ‡∏ö‡πÄ‡∏£‡∏¥‡πà‡∏°‡πÅ‡∏•‡πâ‡∏ß‡∏à‡∏∞‡∏´‡∏≤‡∏¢ flare ‡∏ä‡πâ‡∏≤ / ACR: start ‡πÑ‡∏î‡πâ‡πÄ‡∏•‡∏¢‡πÑ‡∏°‡πà‡πâ‡∏ï‡∏≠‡∏á‡∏£‡∏≠‡∏´‡∏•‡∏±‡∏á‡∏´‡∏≤‡∏¢ flare
		- Start with 100 mg if eGFR < 60
		- HLA-B1502 Screening esp in Asia (Universal Marker) -> SJS/TEN
	- No response to Allopurinol or contraindication to Allopurinol
		- Switch to Febuxostat (ADR: MACE) -> Probenecid (Inhibit OAT URAT transporter, decrease uric acid reabsorption) -> Pegloticase (Recombinant Uricase)
# Osteoporosis
- Associated Note: [[2 Areas/University/Osteoporosis (OP)\|Osteoporosis (OP)]]
- Etiology: drug induced, age related, calcium malsorption
- Pathophysiology: loss of calcium from the bone
- Diagnosis: ‡∏ß‡∏±‡∏î BMD via DXA, calculate T-score
	- T Score > -1 ‡∏õ‡∏Å‡∏ï‡∏¥
	- T Score -1 to -2.5 Osteopenia
	- T Score < -2.5 Osteoporosis
- When to treat? -> Assess Risk and treat according to risk
	- Mild-mod T-score < -1 to -2.5
		- Calcium and Vitamin D ‡πÉ‡∏´‡πâ‡∏û‡∏≠
	- High T-Score < 2.5 or -1 to -2.5 but FRAX >= 3%
		- Calcium and Vitamin D ‡πÉ‡∏´‡πâ‡∏û‡∏≠
		- Thai: Bisphosphonate first line, Denosumab alternative
	- Very High
		- Teriparatide first 1-2 years then continue with Bisphosphonate or Denosumab
		- Romosuzumab 1 year but CI: CVD Disease or Stroke
- Teriparatide
	- Recombinant Parathyroid Hormone
	- ‡∏Ç‡∏ô‡∏≤‡∏î‡∏™‡∏π‡∏á‡∏™‡∏•‡∏≤‡∏¢‡∏Å‡∏£‡∏∞‡∏î‡∏π‡∏Å ‡∏Ç‡∏ô‡∏≤‡∏î‡∏ï‡πà‡∏≥‡πÄ‡∏™‡∏£‡∏¥‡∏°‡∏™‡∏£‡πâ‡∏≤‡∏á‡∏Å‡∏£‡∏∞‡∏î‡∏π‡∏Å
- SERMs
	- Raloxifene indicated if breast cancer risk OR early menopause (before 45 years old)
		- Estrogen agonist @ Ovary
- Hormonal Therapy
    - ‡πÉ‡∏ä‡πâ‡πÄ‡∏õ‡πá‡∏ô‡∏¢‡∏≤‡∏ó‡∏≤‡∏á‡πÄ‡∏•‡∏∑‡∏≠‡∏Å‡πÑ‡∏î‡πâ ‡πÇ‡∏î‡∏¢‡πÄ‡∏£‡∏¥‡πà‡∏°‡πÑ‡∏°‡πà‡πÄ‡∏Å‡∏¥‡∏ô 10 ‡∏õ‡∏µ‡∏´‡∏•‡∏±‡∏á‡∏´‡∏°‡∏î‡∏õ‡∏£‡∏∞‡∏à‡∏≥‡πÄ‡∏î‡∏∑‡∏≠‡∏ô ‡πÅ‡∏•‡∏∞‡∏≠‡∏≤‡∏¢‡∏∏‡πÑ‡∏°‡πà‡πÄ‡∏Å‡∏¥‡∏ô 60 ‡∏õ‡∏µ
    - ‡πÉ‡∏ä‡πâ‡πÉ‡∏ô‡∏Ñ‡∏ô‡∏ó‡∏µ‡πà‡∏´‡∏°‡∏î‡∏õ‡∏£‡∏∞‡∏à‡∏≥‡πÄ‡∏î‡∏∑‡∏≠‡∏ô‡∏Å‡πà‡∏≠‡∏ô‡∏≠‡∏≤‡∏¢‡∏∏ 45 ‡∏õ‡∏µ ‡∏à‡∏ô‡∏Å‡∏ß‡πà‡∏≤‡∏à‡∏∞‡∏ñ‡∏∂‡∏á‡∏≠‡∏≤‡∏¢‡∏∏‡πÄ‡∏â‡∏•‡∏µ‡πà‡∏¢‡∏Ç‡∏≠‡∏á‡∏Å‡∏≤‡∏£‡∏´‡∏°‡∏î‡∏õ‡∏£‡∏∞‡∏à‡∏≥‡πÄ‡∏î‡∏∑‡∏≠‡∏ô
- Calcitonin
	- Not stated in the guideline
- Calcium Requirement
{ #2b3214}

	- Age <= 50: 800 mg elemental/day 
	- Age >= 50 or menopause: 1000 mg elemental/day
- Calcium
	- ‡∏ï‡∏≤‡∏° [[#^2b3214|Requirement]] ‡∏Ç‡πâ‡∏≠‡∏Ç‡πâ‡∏≤‡∏á‡∏ö‡∏ô
	- ‡πÑ‡∏°‡πà‡πÄ‡∏Å‡∏¥‡∏ô 1500 mg/day
	- ‡πÑ‡∏°‡πà‡πÄ‡∏Å‡∏¥‡∏ô 600 elemental/dose
	- CPAC #mnemonics 
		- Calcium Carbonate 40%
		- Calcium Phosphate tribasic 40% 
		- Calcium Acetate 30%
		- Calcium citrate 25%
- Vitamin D
	- if OP: keep 25OHD 30-50 ng/ml
	- Vit D -> ‡∏ï‡∏±‡∏ö -> 25OHD -> ‡πÑ‡∏ï -> 1,25 OHD
	- ‡∏ï‡∏£‡∏ß‡∏à‡πÑ‡∏°‡πà‡πÑ‡∏î‡πâ: supplement ‡πÄ‡∏•‡∏¢ 20,000 U /weekly or 800-2000 u/day
	- Alfacalcidol ‡πÄ‡∏ï‡∏¥‡∏° 1 ‡πÅ‡∏•‡πâ‡∏ß ‡∏î‡∏±‡∏á‡∏ô‡∏±‡πâ‡∏ô‡∏ï‡πâ‡∏≠‡∏á‡∏ú‡πà‡∏≤‡∏ô‡∏ï‡∏±‡∏ö‡∏Å‡πà‡∏≠‡∏ô
	   ![Pasted image 20240317173331.png|400](/img/user/3%20Resources/Attachment/Pasted%20image%2020240317173331.png)
	- Calcifediol ‡πÄ‡∏ï‡∏¥‡∏° 25 ‡πÅ‡∏•‡πâ‡∏ß‡∏î‡∏±‡∏á‡∏ô‡∏±‡πâ‡∏ô‡∏ï‡πâ‡∏≠‡∏á‡∏ú‡πà‡∏≤‡∏ô‡πÑ‡∏ï‡∏Å‡πà‡∏≠‡∏ô
	- Calcitriol = ‡∏ï‡∏±‡∏ß Active

# Osteoarthritis
- Associated Note: [[2 Areas/University/Osteoarthritis\|Osteoarthritis]], [[2 Areas/University/PTHER I/21 - OA\|21 - OA]]
- Etiology: age related, obesity
- Pathophysiology: cartilage destruction
- First line: Topical NSAIDs, Oral NSAID
- Morning Stiffness ‡∏à‡∏∞‡πÑ‡∏°‡πà‡πÄ‡∏Å‡∏¥‡∏ô 30 ‡∏ô‡∏≤‡∏ó‡∏µ ‡∏ï‡πà‡∏≤‡∏á‡∏à‡∏≤‡∏Å RA ‡∏ó‡∏µ‡πà‡πÄ‡∏õ‡πá‡∏ô‡∏ô‡∏≤‡∏ô‡∏Å‡∏ß‡πà‡∏≤‡πÄ‡∏Å‡∏∑‡∏≠‡∏ö 2 ‡∏ä‡∏±‡πà‡∏ß‡πÇ‡∏°‡∏á
- In moderate or sever case: use Intraarticular corticosteroid injections
- Topical capsaicin may benefit in hand OA
	- onset 2 weeks
	- deplete substance-P from sensory neuron
- X-ray is not mandatory, use to follow-up the progression.
- Glucosamine -> inhibit enzyme collagenase and a precursor for proteoglycan
- Chondroitin -> Hyaluronic acid
- Diacerein -> **Anti-IL-1 (ADR: Diarrhea)**, Do not use in elderly, breastfeeding, anthraquinone allergy, age > 65 or < 15
- Life Modification ‡∏™‡∏≥‡∏Ñ‡∏±‡∏ç ‡πÄ‡∏•‡∏µ‡πà‡∏¢‡∏á‡∏Å‡∏≤‡∏£‡πÉ‡∏ä‡πâ‡∏Ç‡πâ‡∏≠‡∏´‡∏ô‡∏±‡∏Å ‡πÄ‡∏•‡∏µ‡πà‡∏¢‡∏á‡∏Å‡∏≤‡∏£‡πÅ‡∏ö‡∏Å‡∏Ç‡∏≠‡∏á‡∏´‡∏ô‡∏±‡∏Å ‡πÄ‡∏•‡∏µ‡πà‡∏¢‡∏á‡∏Å‡∏≤‡∏£‡∏≠‡∏≠‡∏Å‡∏Å‡∏≥‡∏•‡∏±‡∏á‡∏Å‡∏≤‡∏¢‡∏´‡∏ô‡∏±‡∏Å ‡∏≠‡∏¢‡πà‡∏≤ BMI ‡πÄ‡∏Å‡∏¥‡∏ô
	- ‡∏≠‡∏≠‡∏Å‡∏Å‡∏≥‡∏•‡∏±‡∏á‡∏Å‡∏≤‡∏¢‡∏ó‡∏µ‡πà‡∏™‡∏≤‡∏°‡∏≤‡∏£‡∏ñ‡∏ó‡∏≥‡πÑ‡∏î‡πâ ‡πÄ‡∏ä‡πà‡∏ô ‡πÇ‡∏¢‡∏Ñ‡∏∞ ‡∏ß‡πà‡∏≤‡∏¢‡∏ô‡πâ‡∏≥(‡πÄ‡∏û‡∏£‡∏≤‡∏∞‡∏ß‡πà‡∏≤‡∏¢‡∏ô‡πâ‡∏≥‡πÑ‡∏°‡πà‡πÑ‡∏î‡πâ‡πÉ‡∏ä‡πâ‡∏Ç‡πâ‡∏≠‡πÄ‡∏¢‡∏≠‡∏∞ ‡∏Ç‡πâ‡∏≠‡πÑ‡∏°‡πà‡∏ï‡πâ‡∏≠‡∏á‡∏£‡∏±‡∏ö‡∏ô‡πâ‡∏≥‡∏´‡∏ô‡∏±‡∏Å)
	- ‡∏õ‡∏£‡∏∞‡∏Ñ‡∏ö‡∏≠‡∏∏‡πà‡∏ô ‡∏õ‡∏£‡∏∞‡∏Ñ‡∏ö‡πÄ‡∏¢‡πá‡∏ô

# Rheumatoid Arthritis
- Associated Note: [[2 Areas/University/Rheumatoid arthritis\|Rheumatoid arthritis]], [[2 Areas/University/PTHER I/22 - RA\|22 - RA]], [[2 Areas/University/NSAIDs\|NSAIDs]]
- Etiology: genetic related
- Pathophysiology: citrullination, auto antibodies production (APCA, RF)
- Diagnosis
	- X-Ray as gold standard
	- synovial fluid shown increased WBC,
	- RF and APCA may also be found, which can tell disease prognosis
	- ESR and CRP may be elevated, but not specific.
- Disease Activity:
	- ACR/EULAR¬†**‡πÇ‡∏£‡∏Ñ‡∏™‡∏á‡∏ö‡∏´‡∏°‡∏≤‡∏¢‡∏ñ‡∏∂‡∏á‡∏à‡∏≥‡∏ô‡∏ß‡∏ô‡∏Ç‡πâ‡∏≠‡∏ö‡∏ß‡∏° ‚â§ 1 ‡∏Ç‡πâ‡∏≠ ‡∏´‡∏£‡∏∑‡∏≠ SDAI < 3.3**
	- DAS28 **‡∏ô‡πâ‡∏≠‡∏¢‡∏Å‡∏ß‡πà‡∏≤ 2.6 ‡∏™‡∏á‡∏ö**
- Treatment
	- NSAIDs to relief pain, may add tramadol if severe. Use anti-inflammatory dose of NSAIDs
	- Prednisolone 7.5 mg/day, do not use much as it can cause dependence. Taper or discontinue when the DMARDs start showing effects.
	- cDMARDs should be started ASAP
		- Methotrexate
			- Folic acid synthesis inhibitor (dihydrofolate reductase inhibotor)
			- Myelosupression
			- Give folic acid supplement
			- **Do not use in pregnancy** (teratogenic)
			- Do not use in CrCl < 30
			- Monitor Liver function test
		- Leflunomide
			- Pyrimidine synthesis inhibitors
			- Diarrhea, Nausea Vomitting, Hepatic (Jaundice)
			- Stop if ALT > 3 x ULN
			- **Do not use in pregnancy,** if wanted, stop for at least 2 year and use cholestyramine to help eliminating the drug
			- Can be combined with MTX or SFZ
		- Sulfasalazine
			- Can be combined with HCQ and MTX, triple therapy (MTX, SFZ, HCQ)
			- **Do not use in G6PD**
			- **urine and skin discoloration**
			- Caution in pregnancy
		- Hydroxychloroquine
			- Use in Mild OA ONLY
			- **Maybe safest in pregnancy**
			- ADR: Retinal
	- tsDMARDs
		- JAK inhibitor (-nib)
		- serious infections,
		- do not vaccinate live vaccines during the medications.
	- bDMARDs
		- suffix: -mab -cept
		- 3 month onset
		- do not use in HF NYHA class 3/4
		- risk of infection due to immunosupressive -> screen for hepatitis, tuberculin skin test
		- do not vaccinate live vaccines during the medications.